A comprehensive view of West Pharmaceutical Services Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

West to share data about advancements in packaging, containment at CPhl Worldwide Conference in Frankfurt, Germany; data includes solutions for lyophilizatio, NovaPure components with Valor Glass technology for low temperature closure container integrity

West reports Q3 net income down at US$120.6M from US$175.6M a year ago, net sales down 2.8% from a year ago at US$686.9M; proprietary products sales down 1.7% from a year ago to US$567.0M, contract manufacturing sales down 7.5% to US$120.0M

West to present on development of large-volume delivery systems, self-injection devices and prefillable syringe component expertise at 2022 PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Palm Springs, California October 18-19

FDA approves Furoscix furosemide for subcutaneous self-administration by congestive heart failure patients; 80-mg dose is delivered over five hours by on-body Furoscix infusor that uses West’s proprietary SmartDose1 on-body drug delivery technology

West invests US$60.0M to expand Jersey Shore, Pennsylvania, injectable drug component, delivery systems manufacturing facility; Pennsylvania also invests US$5.0M in the expansion project that will create 225 new jobs

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count